Jun 3, 2022
Cell and gene therapies are delicate treatments that require precise temperature control. Often that means ultra-cold temperatures only achieved in long durations with vaporized liquid nitrogen. But shipping with liquid nitrogen poses challenges, and companies within the cell and gene therapy supply chain are exploring scalable solutions for temperature control.
Our most recent white paper highlights the challenges of shipping with vaporized liquid nitrogen, work to achieve a simpler, less expensive storage solution, and the future of cold chain shipping for a market primed for commercialization.
Read the full white paper here.
Image
